Uncovering mechanisms of immune evasion in a novel immunogenic model of KRAS-mutant lung cancer.

被引：0

作者：

Boumelha, Jesse ^{[1
]}

de Carne, Sophie ^{[1
]}

Mugarza, Edurne ^{[1
]}

Romero-Clavijo, Pablo ^{[1
]}

Molina-Arcas, Miriam ^{[1
]}

Downward, Julian ^{[1
]}

机构：

[1] Francis Crick Inst, London, England

来源：

CANCER RESEARCH | 2021年 / 81卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1820

引用

页数：2

共 50 条

[21] A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS [J].

Pang, Xiufeng ;

Liu, Mingyao .

CHINESE JOURNAL OF CANCER, 2016, 35 :92

[22] Targeting metabolic peculiarities: a potentially novel therapeutic approach for KRAS-mutant lung cancer? [J].

Abdel-Rahman, Omar .

JOURNAL OF THORACIC DISEASE, 2016, 8 (08) :E794-E795

[23] ERK MAPK inhibition enhances the immunogenicity of KRAS-mutant colorectal cancer. [J].

Ryan, Meagan B. ;

de la Cruz, Ferran Fece ;

Ahronian, Leanne G. ;

Phat, Sarah ;

Myers, David T. ;

Shahzade, Heather A. ;

Hong, Catriona ;

Corcoran, Ryan B. .

MOLECULAR CANCER RESEARCH, 2020, 18 (05) :76-76

[24] Prognostic values, ceRNA network, and immune regulation function of SDPR in KRAS-mutant lung cancer [J].

Xiaoqing Luo ;

Shunli Peng ;

Sijie Ding ;

Qin Zeng ;

Rong Wang ;

Yueyun Ma ;

ShiYu Chen ;

Yanxia Wang ;

Wei Wang .

Cancer Cell International, 21

[25] Prognostic values, ceRNA network, and immune regulation function of SDPR in KRAS-mutant lung cancer [J].

Luo, Xiaoqing ;

Peng, Shunli ;

Ding, Sijie ;

Zeng, Qin ;

Wang, Rong ;

Ma, Yueyun ;

Chen, ShiYu ;

Wang, Yanxia ;

Wang, Wei .

CANCER CELL INTERNATIONAL, 2021, 21 (01)

[26] Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer [J].

Li, Yunchang ;

Hu, Lanlin ;

Peng, Xinhao ;

Xu, Huasheng ;

Tang, Bo ;

Xu, Chuan .

CANCER DRUG RESISTANCE, 2022, 5 (01) :129-146

[27] Combination Immunotherapy with MEK Inhibitor for Treatment of Kras-Mutant Lung Cancer in Animal Model [J].

Lee, Jong Woo ;

Zhang, Yu ;

Choi, Justin ;

Sharma, Roshan ;

Park, Hee Sun ;

Kaftan, Edward ;

Papadimitrakopoulou, Vassiliki ;

Herbst, Roy ;

Koo, J. Peter .

JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) :S1319-S1319

[28] Impact of co-mutations on the immune microenvironment of KRAS-mutant lung adenocarcinoma [J].

Skoulidis, Ferdinandos ;

Denning, Warren ;

Diao, Lixia ;

Tong, Pan ;

Fan, You Hong ;

Papadimitrakopoulou, Vassiliki ;

Izzo, Julie ;

Behrens, Carmen ;

Kadara, Humam ;

Cuentas, Edwin R. Parra ;

Canales, Jaime Rodriguez ;

Wang, Jing ;

Byers, Lauren A. ;

Wistuba, Ignacio I. ;

Heymach, John V. .

JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) :S13-S14

[29] MAPK regulation of an innate immune response in KRAS-mutant lung adenocarcinoma. [J].

Sisler, Daniel ;

Korpela, Sean ;

Gurule, Natalia ;

Hinz, Trista ;

Marek, Lindsay ;

Bullock, Bonnie ;

Li, Howard ;

Joshi, Molishree ;

Sempeck, Colin ;

Nemenoff, Raphael ;

Heasley, Lynn .

MOLECULAR CANCER RESEARCH, 2020, 18 (05) :76-77

[30] Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC) [J].

Jeanson, Arnaud ;

Tomasini, Pascale ;

Souquet-Bressand, Maxime ;

Brandone, Nicolas ;

Boucekine, Mohamed ;

Grangeon, Mathieu ;

Chaleat, Solene ;

Khobta, Natalyia ;

Milia, Julie ;

Mhanna, Laurent ;

Greillier, Laurent ;

Biemar, Julie ;

Nanni, Isabelle ;

Ouafik, L'houcine ;

Garcia, Stephane ;

Mazieres, Julien ;

Barlesi, Fabrice ;

Mascaux, Celine .

JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (06) :1095-1101

← 1 2 3 4 5 →